• Keine Ergebnisse gefunden

(2)Papachristofilou et al (2019) J Immunother Cancer

N/A
N/A
Protected

Academic year: 2022

Aktie "(2)Papachristofilou et al (2019) J Immunother Cancer"

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Papachristofilou et al (2019) J Immunother Cancer

Figure S2. Heatmap showing broadening of the humoral immune response against antigens in several of the evaluated patients.

Patient serum samples were exposed to the Lung Cancer Antigen Microarray (Serametrix). Arrays were scanned at 635 nm using a microarray scanner (Molecular Devices) and data recorded as Relative Fluorescent Units. Signals greater than threshold were

reported as positive. The threshold value was derived from background, where background = [2.5] x [1st quartile]. Heat maps showing, for each time point and each patient, whether the patient had a signal higher than the 17230 threshold (orange fill). Antigens names covered by BI1361849 are displayed in blue/bold.

(2)

Papachristofilou et al (2019) J Immunother Cancer

Referenzen

ÄHNLICHE DOKUMENTE

At the same time, as mobile internet becomes available and affordable, the mobile device can play as personal access point to private and shared data, as well as applications, which

where α i is the overall gene expression, and C j is the vector of known covariates representing the sample conditions (such as batch membership).. Additive and multiplicative

The characteristics of landslides were also strongly dependent on geology; many deep-seated landslides occurred in the area of alternating beds of mudstone and sandstone, while

Zum 01.01.2015 ist eine Anpassung der Lizenzbedingungen (Entfall der Creative Commons Lizenzbedingung „Keine Bearbeitung“) beabsichtigt, um eine Nachnutzung auch im Rahmen

Interdisziplinäre S2-Leitlinie: Diagnostik und Therapie der Venenthrombose und der Lungenembolie, VASA Volume 39 · S/78 · August 2010.. Leitlinie zur Diagnostik und Therapie

LLFGLALIEV ALKDVEERV FLAKLNNTV SESIKKKVL ASSTLYLVF KVAELVEFL. LTYVSFRNL GAFEHLPSL DLPAYVRNL RLARLALVL FLTGNQLAV

Papachristofilou et al (201 9 ) J Immunother Cancer. Table

Papachristofilou et al (201 9 ) J Immunother Cancer.. Table